Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Vasculitis Clinical Trials

102 recruiting trials for Vasculitis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
102
Total Trials
102
Recruiting Now
8
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT07301892

Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis

Generative AI (GenAI) based on large language models (LLMs) is expected to improve the diagnosis and treatment of autoimmune diseases. We are studying how GenAI may affect the...

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical SciencesEnrolling: 1001 location
RECRUITINGNCT02280733

A Real-World Registry of Chronic Wounds and Ulcers

WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wounds and ulcers. Data...

Sponsor: U.S. Wound RegistryEnrolling: 3000001 location
RECRUITINGNCT05628948

Vascular Lab Resource (VLR) Biorepository

This is a study of biomarkers obtained from prospectively collected subject samples and their correlation with cardiovascular and metabolic diseases. The purpose of this...

Sponsor: The Cleveland ClinicEnrolling: 5001 location
RECRUITINGNCT05251415

Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases

The aim of this project is to start a biological and clinical collection of patients presenting systemic autoimmune disease. This collection will provide appropriate biological...

Sponsor: University Hospital, ToulouseEnrolling: 30001 location
RECRUITINGNCT05383339

Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases

The objective of this work is to identify, in patients with autoimmune diseases, systemic vasculitis and autoinflammatory disease, cytokine and lymphocyte biomarkers of activity...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 22501 location
RECRUITINGNCT07375940

Clinical, Biochemical and Epigenetic Profile of Pediatric Behçet Disease

Behçet disease (BD) is a chronic multisystem inflammatory disorder with a relapsing-remitting course. Pediatric-onset BD is rare and characterized by marked clinical...

Sponsor: Meyer Children's Hospital IRCCSEnrolling: 902 locations
RECRUITINGNCT06271018

TocILizumab in aorTitis in GCA (TILT)

This is a french multicenter observational study assessing safety and efficacy of biosimilar of Tocilizumab in Giant Cell Arteritis (GCA) with active aortitis, including 14...

Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeilEnrolling: 801 location
RECRUITINGNCT05951517

Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura

Henoch Schönlein purpura (HSP) is the most common type of vasculitis in children, with an incidence of \~10/100,000, whereas \>90% of the patients develop symptoms at \<10 years...

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityEnrolling: 241 location
RECRUITINGPhase 2NCT06046222

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

This study will enroll male and female subjects who are 18 years of age or older with Eosinophilic Granulomatosis With Polyangiitis.

Sponsor: NS Pharma, Inc.Enrolling: 4520 locations
RECRUITINGPhase 1NCT07236762

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), including LN and...

Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 181 location
RECRUITINGNCT05437965

National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of...

Sponsor: China National Center for Cardiovascular DiseasesEnrolling: 10001 location
RECRUITINGPhase 3NCT07168161

BDB-001 Phase III Trial in ANCA-Associated Vasculitis

The primary aim is to study the efficacy of treatment with BDB-001 Injection to induce remission in patients with active anti-neutrophil cytoplasmic antibody (ANCA)-associated...

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., LtdEnrolling: 30020 locations
RECRUITINGPhase 3NCT04871191

Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis

The purpose of this study is to identify the most promising therapeutic strategy for patients with granulomatosis with polyangiitis and inadequate response to standard of care...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 421 location
RECRUITINGEarly Phase 1NCT07246096

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of...

A single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA U CAR T cells in patients with autoimmune diseases. 60 patients are...

Sponsor: Changhai HospitalEnrolling: 601 location
RECRUITINGNCT07244614

Ustekinumab in BEhçet's Syndrome STudy

This non-interventional study is an observational cohort with parallel groups aiming primarily to describe the success of biosimilar of ustekinumab in Behçet's syndrome in whom...

Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeilEnrolling: 20811 locations
RECRUITINGPhase 4NCT05854615

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

The goal of this observational, practice-based feasibility study is to observe the efficacy and safety of intramuscular administration of Stempeucel® in Malaysian patients with...

Sponsor: Cell Biopeutics Resources Sdn BhdEnrolling: 31 location
RECRUITINGNCT07037732

Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders

The MONIRITUX study aimed to evaluate whether monitoring (i) circulating B-cell reconstitution or (ii) serum rituximab levels could help identify relapse of autoimmune diseases in...

Sponsor: Centre Hospitalier Universitaire de NiceEnrolling: 501 location
RECRUITINGPhase 1NCT06285279

The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

This study is a single-center, open-label, dose-escalation exploratory clinical trial, expected to enroll 6 to 12 participants. It will use a BOIN (Bayesian Optimal Interval)...

Sponsor: Nanjing University School of MedicineEnrolling: 241 location
RECRUITINGPhase 1NCT06980597

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

This study aims to characterize the safety, tolerability, pharmacokinetics, and preliminary efficacy of OL-108 in relapsed/refractory autoimmune diseases.

Sponsor: Beijing GoBroad HospitalEnrolling: 442 locations
RECRUITINGNCT07275190

The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With...

The purpose of this study is to collect clinical, laboratory, and instrumental data from patients with eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome,...

Sponsor: Fondazione IRCCS Policlinico San Matteo di PaviaEnrolling: 601 location
RECRUITINGPhase 1NCT06978647

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), Systemic Sclerosis...

Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 121 location
RECRUITINGPhase 2NCT06868290

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

The purpose of this study is to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe active Granulomatosis with Polyangiitis...

Sponsor: Novartis PharmaceuticalsEnrolling: 12620 locations
RECRUITINGNCT04919538

Longitudinal Study for Relapsing Polychondritis

Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall...

Sponsor: University of PennsylvaniaEnrolling: 1001 location
RECRUITINGPhase 2NCT07160608

Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated...

The primary objective of this study is to evaluate the safety and tolerability of tarperprumig in participants with newly diagnosed or relapsing anti-neutrophil cytoplasmic...

Sponsor: Alexion Pharmaceuticals, Inc.Enrolling: 7520 locations
RECRUITINGNCT06642870

Rare AutoImmune SElf-management Programme Development

The rare autoimmune rheumatic diseases (RAIRDs) are life-long multi-system diseases that are life or organ threatening. RAIRDs can impair quality of life similar to chronic...

Sponsor: University of the West of EnglandEnrolling: 3601 location
RECRUITINGPhase 3NCT05767047

A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis

The primary objective of this study is to evaluate the long-term safety of apremilast in subjects 2 years of age or older with oral ulcers associated with Behçets disease or 5...

Sponsor: AmgenEnrolling: 487 locations
RECRUITINGNCT06462768

Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis

Systemic SClerosis (SSC) is a systemic disease characterized by limited or diffuse cutaneous sclerosis, microangiopathy, overproduction of autoantibodies and variable organ damage...

Sponsor: CHU de ReimsEnrolling: 2601 location
RECRUITINGPhase 1NCT07104721

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), including LN and...

Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 181 location
RECRUITINGNCT03004326

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.

Sponsor: Peter MerkelEnrolling: 5010 locations
RECRUITINGPhase 3NCT06983821

Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)

The purpose of this study is to determine the safety and efficacy of a therapeutic regimen consisting of 4 weeks of glucocorticoids given with a combination of the usual induction...

Sponsor: Ottawa Hospital Research InstituteEnrolling: 362 locations
RECRUITINGNCT04278404

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of...

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults...

Sponsor: Duke UniversityEnrolling: 500020 locations
RECRUITINGNCT06593041

ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS

Blood platelets, well known for their role in hemostasis, are abnormally activated in patients suffering from systemic lupus erythematosus (SLE), but also from other...

Sponsor: University Hospital, Strasbourg, FranceEnrolling: 4501 location
RECRUITINGNCT05865054

Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)

The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and...

Sponsor: University of PennsylvaniaEnrolling: 4004 locations
RECRUITINGPhase 3NCT04656184

A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients...

Kawasaki disease (KD) is the most frequent vasculitis in younger children \<5years, and the first cause of acquired ischemic myocardiopathy in childhood. Exceptionally, KD may...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 841 location
RECRUITINGPhase 1NCT07123519

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), including LN and...

Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 181 location
RECRUITINGNCT05479448

Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell...

This prospective study is to explore different predictive factors for response to steroid treatment in patients with PMR and/or GCA. It evaluates the association of endogenous GC...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 301 location
RECRUITINGPhase 2NCT04629144

Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to...

Cryoglobulinemia vasculitis (CV) is a systemic immune-mediated small vessel vasculitis. Rituximab proved effective on main vasculitis signs, with a complete clinical response of...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 4820 locations
RECRUITINGNCT07351422

Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis

This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition. To achieve this, two separate questionnaires will...

Sponsor: University of EdinburghEnrolling: 501 location
RECRUITINGNCT06758271

Special Drug Use-results Survey for Long-term Use(Avacopan)

The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with...

Sponsor: Kissei Pharmaceutical Co., Ltd.Enrolling: 2501 location
RECRUITINGNCT06004154

Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim)

Giant cell arteritis (GCA), also known as Horton's disease, is an inflammatory arteritis of the large and medium-sized arteries, with an estimated incidence of 17.8/100,000 in...

Sponsor: Fondation Ophtalmologique Adolphe de RothschildEnrolling: 501 location
RECRUITINGPhase 4NCT06498089

A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision...

This study aimed to compare the efficacy and safety of a precision treatment regimen based on clinical-molecular phenotypes with a conventional treatment regimen in the treatment...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 1241 location
RECRUITINGPhase 1 / Phase 2NCT06733935

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019...

Sponsor: Nkarta, Inc.Enrolling: 14415 locations
RECRUITINGPhase 3NCT06145893

A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease

This is a phase 3, multi-center, randomized, placebo-controlled, double-blind, parallel-group study with an equal randomization among the Hemay005 high dose, lower dose and...

Sponsor: Ganzhou Hemay Pharmaceutical Co., LtdEnrolling: 16220 locations
RECRUITINGPhase 4NCT05965284

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

This study is a prospective, open-labelled, randomized, controlled, single-center clinical trial. The aim of this study is to compare the remission rate of patients treated with...

Sponsor: Chinese SLE Treatment And Research GroupEnrolling: 401 location
RECRUITINGPhase 2NCT07108387

Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis

This is a multi-center, randomized, open label study that will assess the efficacy and safety of ACTEMRA(R) or one of its FDA-approved biosimilars Tocilizumab (TCZ) maintenance...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 787 locations
RECRUITINGNCT06279065

Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis

The longitudinal observational study aims to assess the impact of the microbiome especially the gut-microbiome in the emergence and course of giant cell arteritis (abbr. GCA)...

Sponsor: University of BonnEnrolling: 502 locations
RECRUITINGNCT00315380

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the...

Sponsor: University of PennsylvaniaEnrolling: 70013 locations
RECRUITINGPhase 4NCT06072482

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Sponsor: AmgenEnrolling: 30020 locations
RECRUITINGNCT06508346

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV

This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of childhood-onset refractory ANCA-Associated...

Sponsor: The Children's Hospital of Zhejiang University School of MedicineEnrolling: 121 location

Showing 50 of 102 trials.Search all Vasculitis trials